Myriad outcomes
Restores
tissue
Vascularized tissue coverage in as little as 7 days and volumetric fill in 3 weeks.1-4
Minimal complications
Low infection and graft loss rates, even in contaminated defects.1-8
Single
application
A median of one product application1-8
The Residual Myriad difference
- As Myriad incorporates into the developing tissue, it is broken down and remodeled
- As it integrates, Residual Myriad is observed as varying levels of intact product (typically a creamy golden substance)
- Until completely remodeled , Residual Myriad continues to add structure and biology to the developing tissue
- Residual Myriad should be expected, and is beneficial for the formation of functional tissue
Myriad surgical case studies
Pre-operative Assessment
8 Months
Initial Assessment
Day 56
Michael Cormican, MD
CC.0156
Intra-operative Defect
Post-op Week 12
Richard Kaufman, DPM, CWSP
CC.0037
Wide Excision
3 Months post STSG
Abigail E. Chaffin, MD, FACS, CWSP, MAPWCA
CC.0078
A portfolio for soft tissue repair
Myriad Matrix™
Multiple layers of AROA ECM™ to enable regeneration of organized, functional tissue.
Myriad Morcells™
A conformable graft of morselized Myriad. Ideal for irregular, tunneled or undermined wounds.
Myriad Morcells Fine™
A finer particulate of Myriad Morcells. Ideal for irregular, tunneled or undermined wounds.
Ordering
Find out how to order the Myriad portfolio for use within your healthcare facility.
Reimbursement
Our specialist reimbursement team are here to provide you with comprehensive coding and coverage support.
AROA ECM™
Our platform technology
Derived from ovine forestomach, the AROA ECM technology is a patented platform for our soft tissue repair and reconstruction portfolio. It regenerates functional tissue, enabling clinicians to achieve more for patients.